Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
2
×
life sciences
national blog main
new york blog main
new york top stories
san francisco
2
×
san francisco blog main
2
×
san francisco top stories
startups
10x genomics
acetylon pharmaceuticals
ambys medicines
biotech ipos
boston blog main
boston top stories
cell therapy
clinical trials
constellation pharmaceuticals
desmoid tumors
dihydroergotamine
gene therapy
genentech
generic drugs
holger willenbring
investing
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
medical device
national top stories
nirogacestat
oregon stem cell center
pfizer
proteon therapeutics
rare diseases
What
biotech
2
×
aiming
ambys
big
boost
companies
control
deadly
deal
debuted
diseases
followed
formed
future
genomics
haul
ipo
launch
led
life
liver
make
markets
medicines
new
public
satsuma
science
springworks
startup
street
takeda
today
treatments
unusual
variety
wall
way
wednesday
week
Language
unset
Current search:
deals
×
" san francisco blog main "
×
" san francisco "
×
biotech
×
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
